Skip to main content
High RiskFDAfda-F-1617-2015UNDECLARED ALLERGEN

Mini Naan Eight (8) nann packaged in coated paper printed board and transparent wrap with a net weight of 12.6 oz (360 g) per package and...

Category
Units Affected
7,783
Recall Date
November 26, 2014
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1617-2015.

The products were shipped without labels declaring the nutrition and ingredients information and the presence of egg, milk, and wheat allergens.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1617-2015.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Fgf Brands, Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1617-2015.

fgf brands, inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Fgf Brands, Inc Recall FAQ

Fgf Brands, Inc is the subject of a frozen food safety report: Mini Naan Eight (8) nann packaged in coated paper printed board and transparent wrap with a net weight of 12.6 oz (360 g) per package and.... The notice was published on November 26, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 7,783 units are potentially affected.